Sylogist (TSE:SYZ – Get Free Report) had its price target decreased by stock analysts at ATB Cormark Capital Markets from C$5.50 to C$4.75 in a research report issued on Thursday,BayStreet.CA reports. The firm currently has a “speculative buy” rating on the stock. ATB Cormark Capital Markets’ price target points to a potential upside of 42.22% from the company’s current price.
Sylogist Trading Down 1.8%
Shares of TSE:SYZ traded down C$0.06 during midday trading on Thursday, hitting C$3.34. 9,129 shares of the stock were exchanged, compared to its average volume of 80,024. The business’s 50-day moving average price is C$3.57 and its 200 day moving average price is C$3.70. Sylogist has a 12 month low of C$3.03 and a 12 month high of C$9.16. The stock has a market capitalization of C$77.81 million, a price-to-earnings ratio of -10.44 and a beta of 0.25. The company has a debt-to-equity ratio of 70.73, a quick ratio of 0.51 and a current ratio of 0.76.
Sylogist (TSE:SYZ – Get Free Report) last posted its quarterly earnings data on Tuesday, May 12th. The company reported C($0.16) earnings per share for the quarter. Sylogist had a negative return on equity of 24.29% and a negative net margin of 12.41%.The business had revenue of C$14.74 million during the quarter. Analysts predict that Sylogist will post 0.2447905 earnings per share for the current year.
Insider Buying and Selling
About Sylogist
Sylogist provides mission-critical SaaS solutions to over 2,000 public sector customers across the government, nonprofit, and education market segments. The Company’s stock is traded on the Toronto Stock Exchange under the symbol SYZ. Information about Sylogist, inclusive of full financial statements together with Management’s Discussion and Analysis, can be found at sedarplus.ca or at sylogist.com.
Recommended Stories
- Five stocks we like better than Sylogist
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for Sylogist Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sylogist and related companies with MarketBeat.com's FREE daily email newsletter.
